ACE-inhibitory peptides from jumbo squid collagen were encapsulated in stable nanoliposomes (53% efficiency, 70 nm diameter) and incorporated into fish gelatin gels without losing their bioactive properties.
IC50 = 0.096 g/LThe squid tunic-derived peptide fraction showed strong ACE-inhibitory activity at a very low concentration, indicating potent blood pressure-lowering potential.
What the researchers found
Peptides with strong ACE-inhibitory activity (IC50 = 0.096 g/L) from squid tunics were successfully encapsulated in phosphatidylcholine nanoliposomes with 53% efficiency at an optimal concentration of 1.75 g/L. The liposomes remained stable and maintained their negative zeta potential (~-59 mV) and size (~70 nm) over one week at 4 °C and pH 3-7. Incorporation into fish gelatin did not affect gel properties, and the ACE-inhibitory activity was preserved.
Why it matters
This study demonstrates a method to protect bioactive peptides during food processing and storage, enhancing their potential as functional ingredients for managing blood pressure through diet.
How the study worked
Peptides under 1 kDa were isolated from hydrolyzed squid tunics and encapsulated in phosphatidylcholine nanoliposomes at varying concentrations. Liposome stability, size, and zeta potential were measured over time. The peptide-loaded liposomes were then incorporated into fish gelatin gels, and rheological and thermal properties were assessed alongside ACE-inhibitory activity.
What this study cannot tell us
The study does not report in vivo efficacy or long-term stability beyond one week, and the impact on human health outcomes remains to be tested.
How to read the evidence
This is a food technology study demonstrating peptide encapsulation and incorporation into a food matrix. The ACE-inhibitory activity was measured in vitro only. No animal or human studies were conducted to confirm blood pressure-lowering effects of the final product.
When this study was published
Published in 2016, this study is about a decade old. Nanoliposome encapsulation for bioactive peptides has continued to develop, but this specific squid peptide product has not appeared in clinical studies.
The bigger picture
Delivering bioactive peptides through food is challenging because digestion and food processing can destroy their activity. Nanoliposome encapsulation is a promising solution that protects peptides while enabling their incorporation into real food products. This study is part of a growing trend in 'functional food engineering' — using nanotechnology to make health-promoting foods that actually deliver their bioactive ingredients intact.
Questions still open
- Do the liposome-encapsulated peptides survive gastrointestinal digestion and reach the bloodstream in active form?
- Would regular consumption of this functional gelatin product actually lower blood pressure in humans?
- How does long-term storage (beyond one week) affect the liposome stability and peptide activity?
Common questions
Why put peptides inside nanoliposomes instead of adding them directly to food?
Could eating this gelatin product actually help with blood pressure?
Read the original research
Incorporation of liposomes containing squid tunic ACE-inhibitory peptides into fish gelatin.
Journal of the science of food and agriculture, 96(3), 769-76
Citation
Mosquera, Mauricio; Giménez, Begoña; Montero, Pilar; Gómez-Guillén, Maria Carmen. (2016). Incorporation of liposomes containing squid tunic ACE-inhibitory peptides into fish gelatin.. Journal of the science of food and agriculture, 96(3), 769-76. https://doi.org/10.1002/jsfa.7145